Abstract
Bone marrow is the most common site of extranodal involvement in lymphoid neoplasms, and evaluation of bone marrow is an important process in the work-up of patients with lymphoma. Different lymphomas often demonstrate characteristic infiltration patterns in the bone marrow. Familiarity with patterns of marrow involvement can help in the differentiation of reactive and neoplastic lymphoid infiltrates as well as the subclassification of lymphomas in the bone marrow. This chapter summarizes the key pathological features of common mature B- and T-cell non-Hodgkin lymphomas and Hodgkin lymphomas in the bone marrow, discusses the diagnostic challenges, and emphasizes the importance of integration of morphologic findings with the results of ancillary studies and clinical context in the evaluation of bone marrow involvement by lymphoid neoplasms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Martinez A, Ponzoni M, Agostinelli C, Hebeda KM, Matutes E, Peccatori J, et al. Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-Hodgkin lymphomas. Am J Surg Pathol. 2012;36(2):296–304.
Fend F, Kremer M. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy. Pathobiology. 2007;74(2):133–43.
Shipp MA. Prognostic factors in aggressive non-Hodgkin’s lymphoma: who has “high-risk” disease? Blood. 1994;83(5):1165–73.
McKenna RW, Hernandez JA. Bone marrow in malignant lymphoma. Hematol Oncol Clin North Am. 1988;2(4):617–35.
Yan Y, Chan WC, Weisenburger DD, Anderson JR, Bast MA, Vose JM, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol. 1995;13(6):1336–42.
Lambertenghi-Deliliers G, Annaloro C, Soligo D, Oriani A, Pozzoli E, Quirici N, et al. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol. 1992;65(2):61–5.
Howell SJ, Grey M, Chang J, Morgenstern GR, Cowan RA, Deakin DP, et al. The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol. 2002;119(2):408–11.
Levy R, Colonna P, Tourani JM, Gastaut JA, Brice P, Raphael M, et al. Human immunodeficiency virus associated Hodgkin’s disease: report of 45 cases from the French Registry of HIV-Associated Tumors. Leuk Lymphoma. 1995;16(5–6):451–6.
Bain BJ. Bone marrow trephine biopsy. J Clin Pathol. 2001;54(10):737–42.
Navone R, Colombano MT. Histopathological trephine biopsy findings in cases of ‘dry tap’ bone marrow aspirations. Appl Pathol. 1984;2(5):264–71.
Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin’s lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005;29(12):1549–57.
Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K. Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood. 2015;127(8):965–70.
Costes V, Duchayne E, Taib J, Delfour C, Rousset T, Baldet P, et al. Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes. Br J Haematol. 2002;119(4):916–22.
Merli M, Arcaini L, Boveri E, Rattotti S, Picone C, Passamonti F, et al. Assessment of bone marrow involvement in non-Hodgkin’s lymphomas: comparison between histology and flow cytometry. Eur J Haematol. 2010;85(5):405–15.
Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, et al. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol. 2016;43(12):1161–6.
Nielson C, Fischer R, Fraga G, Aires D. Loss of CD30 expression in anaplastic large cell lymphoma following Brentuximab therapy. J Drugs Dermatol. 2016;15(7):894–5.
Wilkins BS. Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis. J Clin Pathol. 2011;64(5):380–6.
Thiele J, Zirbes TK, Kvasnicka HM, Fischer R. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline. J Clin Pathol. 1999;52(4):294–300.
Sovani V, Harvey C, Haynes AP, McMillan AK, Clark DM, O’Connor SR. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings. J Clin Pathol. 2014;67(5):389–95.
Torlakovic E, Torlakovic G, Brunning RD. Follicular pattern of bone marrow involvement by follicular lymphoma. Am J Clin Pathol. 2002;118(5):780–6.
Wool GD, Deucher A. Bone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. Am J Clin Pathol. 2015;143(2):201–13; quiz 306.
Kremer M, Spitzer M, Mandl-Weber S, Stecker K, Schmidt B, Hofler H, et al. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Investig. 2003;83(1):107–14.
Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100(2):635–9.
Kalpadakis C, Pangalis GA, Sachanas S, Vassilakopoulos TP, Kyriakaki S, Korkolopoulou P, et al. New insights into monoclonal B-cell lymphocytosis. Biomed Res Int. 2014;2014:258917.
Randen U, Tierens AM, Tjonnfjord GE, Delabie J. Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns. Am J Clin Pathol. 2013;139(3):390–5.
Nelson BP, Abdul-Nabi A, Goolsby C, Winter J, Peterson L. Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations. Am J Clin Pathol. 2014;141(5):687–96.
Labouyrie E, Marit G, Vial JP, Lacombe F, Fialon P, Bernard P, et al. Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol. 1997;10(10):1015–20.
Mollejo M, Menarguez J, Lloret E, Sanchez A, Campo E, Algara P, et al. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol. 1995;19(10):1146–57.
Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, Dewald GW. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol. 2002;161(1):63–71.
Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med. 2012;367(9):826–33.
Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, et al. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch. 2016;468(3):259–75.
Johrens K, Stein H, Anagnostopoulos I. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines. Am J Surg Pathol. 2007;31(8):1181–5.
Sherman MJ, Hanson CA, Hoyer JD. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia. Am J Clin Pathol. 2011;136(3):390–9.
Dogan A, Morice WG. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol. 2004;127(2):140–54.
Khokhar FA, Payne WD, Talwalkar SS, Jorgensen JL, Bueso-Ramos CE, Medeiros LJ, et al. Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol. 2010;41(1):79–87.
Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Huh J. Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement. Am J Clin Pathol. 2009;131(5):640–6.
Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia. 2000;14(6):991–7.
Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, et al. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol. 2001;116(3):410–9.
Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, et al. Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol. 2016;40(5):676–88.
Wang CC, Tien HF, Lin MT, Su IJ, Wang CH, Chuang SM, et al. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity. Genes Chromosomes Cancer. 1995;12(3):161–4.
Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005;123(2):200–5.
Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121(22):4504–11.
Viswanatha DS, Foucar K, Berry BR, Gascoyne RD, Evans HL, Leith CP. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol. 2000;13(7):825–33.
Ondrejka SL, Lai R, Smith SD, Hsi ED. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 2011;96(8):1121–7.
Wong KF, Chan JK, Cheung MM, So JC. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon. Am J Clin Pathol. 2001;115(2):266–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Xie, Y. (2020). Bone Marrow Involvement by Lymphoid Neoplasms. In: Wang, E., Lagoo, A.S. (eds) Practical Lymph Node and Bone Marrow Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-32189-5_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-32189-5_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-32188-8
Online ISBN: 978-3-030-32189-5
eBook Packages: MedicineMedicine (R0)